Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-25 @ 4:44 PM
Study NCT ID:
NCT04039503
Status:
COMPLETED
Last Update Posted:
2022-01-12
First Post:
2019-07-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-30
First Submit QC Date:
None
Study First Post Date:
2019-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-12
Results First Submit QC Date:
None
Results First Post Date:
2022-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-12
Last Update Post Date:
2022-01-12
Last Update Post Date Type:
ACTUAL